Abstract
p21Waf1/Cip1/Sdi1 is a potent inhibitor of cyclin-dependent kinases (CDKs) and one of the best characterized p53 direct target genes. Moreover, it is one of the principal inducers of senescence, a permanent arrest phenotype related to ageing and the prevention of cell transformation. It was initially thought that p21 had tumour suppressor properties, due to its ability to stop cell cycle at different stages, either transitorily or permanently. However, recent evidence points to a much more complex picture. It is now well established that p21 itself can trigger apoptosis in certain situations, even independently of p53. On the other hand, p21-mediated cell arrest can actually limit the sensitivity to apoptotic stimuli. To complicate matters even further, p21 has been shown to have other direct pro-survival functions and could even be contributing to tumourigenesis through the secretion of growth factors by arrested cells. At the core of these antagonistic functions of p21 is the generation of Reactive Oxygen Species (ROS), which have been shown to be important both in the induction of apoptosis and the establishment of senescence, and could also participate in the negative effects on tissue homeostasis of the senescent cell secretome. p21 has the ability to stop cancer cell growth and is not mutated in cancer. However, without a better understanding of its pleiotropic functions we will not be able to harness its clinical potential. It is therefore important to investigate the mechanisms by which p21 affects cell physiology and its use of ROS as messengers and effectors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbas T, Dutta A (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9:400–414
Bai J, Cederbaum AI (2003) Catalase protects HepG2 cells from apoptosis induced by DNA-damaging agents by accelerating the degradation of p53. J Biol Chem 278:4660–4667
Barzilai A, Yamamoto K (2004) DNA damage responses to oxidative stress. DNA Repair 3:1109–1115
Borgdorff V, Lleonart ME, Bishop CL, Fessart D, Bergin AH, Overhoff MG, Beach DH (2010) Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 29:2262–2271
Broude EV, Demidenko ZN, Vivo C, Swift ME, Davis BM, Blagosklonny MV, Roninson IB (2007a) p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 6:1468–1471
Broude EV, Swift ME, Vivo C, Chang BD, Davis BM, Kalurupalle S, Blagosklonny MV, Roninson IB (2007b) p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 26:6954–6958
Campisi J, Kim S, Lim CS, Rubio M (2001) Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 36:1619–1637
Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC, Roninson IB (2000a) p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 19:2165–2170
Chang BD, Watanabe K, Broude EV, Fang J, Poole JC, Kalinichenko TV, Roninson IB (2000b) Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad Sci USA 97:4291–4296
Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, Zhang DD (2009) Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 34:663–673
Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363–9367
el-Deiry WS, Harper JW, O’Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169–1174
Gartel AL (2005) The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis. Leuk Res 29:1237–1238
Hampton MB, Orrenius S (1998) Redox regulation of apoptotic cell death in the immune system. Toxicol Lett 102–103:355–358
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin- dependent kinases. Cell 75:805–816
Helmbold H, Komm N, Deppert W, Bohn W (2009) Rb2/p130 is the dominating pocket protein in the p53-p21 DNA damage response pathway leading to senescence. Oncogene 28:3456–3467
Inoue T, Kato K, Kato H, Asanoma K, Kuboyama A, Ueoka Y, Yamaguchi SI, Ohgami T, Wake N (2009) Level of reactive oxygen species induced by p21(WAF(1)CIP(1)) is critical for the determination of cell fate. Cancer Sci 100(7):1275–1283
Lee AC, Fenster BE, Ito H, Takeda K, Bae NS, Hirai T, Yu ZX, Ferrans VJ, Howard BH, Finkel T (1999) Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J Biol Chem 274:7936–7940
Lin JH, Morikawa T, Chan AT, Kuchiba A, Shima K, Nosho K, Kirkner G, Zhang SM, Manson JE, Giovannucci E, Fuchs CS, Ogino S (2012) Postmenopausal hormone therapy is associated with a reduced risk of colorectal cancer lacking CDKN1A expression. Cancer Res 72:3020–3028
Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW, Aaronson SA (2002) Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J 21:2180–2188
Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA (2003) Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol 23:8576–8585
Macip S, Kosoy A, Lee SW, O’Connell MJ, Aaronson SA (2006) Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G2 checkpoint. Oncogene 25:6037–6047
Masgras I, Carrera S, de Verdier PJ, Brennan P, Majid A, Makhtar W, Tulchinksy E, Jones GD, Roninson IB, Macip S (2012) Reactive oxygen species and mitochondrial sensitivity to oxidative stress determine induction of cancer cell death by p21. J Biol Chem 23 287(13):9845–9854
Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, del Moore VG, Deng J, Anderson KC, Richardson P, Tai YT, Mitsiades CS, Matulonis UA, Drapkin R, Stone R, Deangelo DJ, McConkey DJ, Sallan SE, Silverman L, Hirsch MS, Carrasco DR, Letai A (2011) Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334:1129–1133
Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90–98
Passos JF, Nelson G, Wang C, Richter T, Simillion C, Proctor CJ, Miwa S, Olijslagers S, Hallinan J, Wipat A, Saretzki G, Rudolph KL, Kirkwood TB, von Zglinicki T (2010) Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol Syst Biol 6:347
Rego MA, Harney JA, Mauro M, Shen M, Howlett NG (2012) Regulation of the activation of the fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor. Oncogene 31:366–375
Roninson IB (2002) Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179:1–14
Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63:2705–2715
Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512
te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP (2002) DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62:1876–1883
Tsao YP, Huang SJ, Chang JL, Hsieh JT, Pong RC, Chen SL (1999) Adenovirus-mediated p21((WAF1/SDII/CIP1)) gene transfer induces apoptosis of human cervical cancer cell lines. J Virol 73:4983–4990
von Zglinicki T, Saretzki G, Docke W, Lotze C (1995) Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 220:186–193
Acknowledgements
This work was supported by the MRC and the University of Leicester. The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Masgras, I., Macip, S. (2013). p21 Mediates Senescence by a Mechanism Involving Accumulation of Reactive Oxygen Species. In: Hayat, M. (eds) Tumor Dormancy, Quiescence, and Senescence, Volume 1. Tumor Dormancy and Cellular Quiescence and Senescence, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5958-9_13
Download citation
DOI: https://doi.org/10.1007/978-94-007-5958-9_13
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5957-2
Online ISBN: 978-94-007-5958-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)